Trial intelligence / Profile preview

Topical Sildenafil Liposomes vs Minoxidil for Alopecia Areata

NCT06527729Phase 1Completed

Sponsor
Assiut University
Start
Jul 2021
Primary completion
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of sildenafil in alopecia areata (2 arms), sponsored by Assiut University. Primary endpoints: Efficacy of topical sildenafil-loaded liposomes compared with minoxidil (SALT score and hair regrowth percentage) at 8 weeks and Dermoscopic assessment of hair features at 8 weeks. Started Jul 2021; status: completed.

02

Drugs

sildenafil
03

Conditions

alopecia areata

Beyond the preview

Go deeper on NCT06527729.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06527729.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call